Honored to host FDA‘s own Jim Traficant for a discussion on rare diseases.
His personal story is captivating and inspiring — we’re grateful to have him.
🚨 LIVE: FDA's #RareDiseaseDay virtual event! Topics include FDA’s Rare Disease Innovation Hub, clinical trials, AI, real-world evidence & patient engagement.
Join now: https://www.youtube.com/live/B6bGjpQVqEs
#FDA #RareDisease
This could not be further from the truth. This administration has addressed a roadblock that prohibited companies using natural colors from highlighting that fact on the labeling.
Under the old way, companies that used only natural color were forced to call them “artificial” when making labeling claims, creating consumer confusion and disincentivizing use. Fixing this issue will help companies continue to transition to using natural color alternatives as part of an industry wide phase out. Follow FDA’s dye removal tracker at https://www.fda.gov/food/color-additives-information-consumers/tracking-food-industry-pledges-remove-petroleum-based-food-dyes
As shown on FDA’s list of chemicals under review https://www.fda.gov/food/food-chemical-safety/list-select-chemicals-food-supply-under-fda-review FDA is actively reviewing the safety of titanium dioxide. We have already received numerous commitments from industry leaders to abandon the use of TiO2.
The FDA has a moral duty to move quickly to get meaningful treatments to patients.
Are you living with Primary Sclerosing Cholangitis (PSC) or caring for a loved one with PSC? Share your experience with FDA staff during a virtual Patient Listening Session on April 30, 2026. To be considered for the session, fill out this survey by March 3, 2026: https://qualtricsxmjqffz4ktl.qualtrics.com/jfe/form/SV_3xbePqkVXSOlVQy
Hospital contracting and IRB reviews need to move much faster.
Join us for the FDA Grand Rounds Feb. 19. Dr. Ronit Mazor, a principal investigator in the FDA’s Gene Transfer Immunogenicity Branch in CBER, will discuss gene therapy technology and examine the immunological challenges facing AAV gene therapy.
http://www.FDA.gov/GrandRounds
FDA HQ will be part of #LightUpForRare during #RareDiseaseWeek. Every rare disease matters. View the agenda for the #FDARareDiseaseDay virtual public meeting on Monday, February 23! Registration is open and free: http://www.fda.gov/RareDiseaseDay
Experiencing menopause symptoms? FDA has requested updates to hormone replacement therapy (HRT) labels, removing certain risk statements from boxed warnings.
Several companies have already made FDA-approved changes. HRT can help with hot flashes, night sweats & vaginal dryness. Talk to your healthcare provider to see if it's right for you. Learn more ⬇️ https://www.fda.gov/consumers/consumer-updates/hormone-replacement-therapies-can-help-women-bothersome-menopausal-symptoms
Be heard at the FDA: We’re hosting a virtual Patient Listening Session on Primary Sclerosing Cholangitis (PSC) on April 30, 2026. If you are a patient living with PSC and interested in sharing your experiences with the FDA, fill out this survey by March 3, 2026. https://qualtricsxmjqffz4ktl.qualtrics.com/jfe/form/SV_3xbePqkVXSOlVQy
#PSC #IBD
The FDA approved labeling changes to 6 menopausal hormone therapy (HRT) products to clarify risk considerations. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products
Thanks to the leadership of @DrMakaryFDA and @SecKennedy, the black box warnings on these products have been removed, a huge step forward in advancing women's health.
The FDA approved a first-of-its-kind device to treat locally advanced pancreatic cancer, reflecting the agency’s unwavering commitment to advancing safe and effective medical devices that address chronic diseases and improve the lives of Americans. https://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-device-treat-pancreatic-cancer
Have you seen on your food packaging ingredients like BHA, BHT, and azodicarbonamide?
@US_FDA is going to take a hard look at these chemicals. Read today's announcement:
https://www.fda.gov/news-events/press-announcements/fda-launches-assessment-bha-common-food-chemical-preservative
Today, the FDA issued a Request for Information to re-assess the safety of butylated hydroxyanisole (BHA) using the latest scientific information. https://www.fda.gov/news-events/press-announcements/fda-launches-assessment-bha-common-food-chemical-preservative
What's behind the sudden rise in food allergies?
Join us live on February 25 at 1pm for a panel discussion with top experts in the field!
https://www.fda.gov/patients/fda-expert-panels/fda-expert-panel-food-allergies-02252026
FDA cannot verify the quality, safety, or efficacy of non-FDA approved drugs. https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs
Today, the FDA is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies — including Hims & Hers and other compounding pharmacies — as similar alternatives to FDA-approved drugs. https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs
Thank you for sharing your story Mike — and delivering the most important message in Super Bowl history.
We don’t have to be the sickest country in the developed world.
The answer is simple: EAT REAL FOOD.
Today is National Wear Red Day❤️. #DYK #heartdisease is the leading cause of death for women? Read and share our tips to help you make good decisions about your heart health.
http://www.fda.gov/womenshearthealth #WearRedDay